{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:53:08Z","timestamp":1790232788594,"version":"4.1.0"},"reference-count":17,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T00:00:00Z","timestamp":1536278400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"DOI":"10.3389\/fneur.2018.00756","type":"journal-article","created":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T00:33:33Z","timestamp":1536280413000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":27,"title":["24S-Hydroxycholesterol Correlates With Tau and Is Increased in Cerebrospinal Fluid in Parkinson's Disease and Corticobasal Syndrome"],"prefix":"10.3389","volume":"9","author":[{"given":"Ingemar","family":"Bj\u00f6rkhem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalicharan","family":"Patra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam L.","family":"Boxer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Svenningsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,9,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1161\/01.ATV.0000120374.59826.1b","article-title":"Brain cholesterol\u2013long secret life behind a barrier","volume":"24","author":"Bj\u00f6rkhem","year":"2004","journal-title":"Arterioscl Thromb Vasc Biol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1194\/jlr.M500024-JLR200","article-title":"Crossing the barrier: net flux of 27-hydroxycholesterol into the human brain and possible consequences for cerebral cholesterol homeostasis","volume":"46","author":"Heverin","year":"2005","journal-title":"J Lipid Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.neulet.2005.11.046","article-title":"Are the CSF levels of 24S-hydroxycholesterol a suitable biomarker for mild cognitive impairment?","volume":"397","author":"Leoni","year":"2006","journal-title":"Neurosci Lett."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1007\/s00018-015-1839-9","article-title":"Cellular factors modulating the mechanism of tau protein aggregation","volume":"72","author":"Fontaine","year":"2015","journal-title":"Cell Mol Life Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.neulet.2007.08.014","article-title":"Levels of ApoE in cerebrospinal fluid are correlated with Tau and 24S-hydroxycholesterol in patients with cognitive disorders","volume":"425","author":"Shafaati","year":"2007","journal-title":"Neurosci Lett."},{"key":"B6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.bcp.2012.12.007","article-title":"Cerebral and extracerebral cholesterol metabolism and CSF markers of Alzheimer's disease","volume":"86","author":"Popp","year":"2013","journal-title":"Biochem Pharmacol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00018-016-2351-6","article-title":"Back to the tubule: microtubule dynamics in Parkinson's disease","volume":"74","author":"Pellegrini","year":"2017","journal-title":"Cell Mol Life Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","article-title":"Criteria for the diagnosis of corticobasal degeneration","volume":"80","author":"Armstrong","year":"2013","journal-title":"Neurology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/ana.22424","article-title":"Clinicopathological correlations in corticobasal degeneration","volume":"70","author":"Lee","year":"2011","journal-title":"Ann Neurol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1001\/archneur.56.1.33","article-title":"Diagnostic criteria for Parkinson disease","volume":"56","author":"Gelb","year":"1999","journal-title":"Arch Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1046\/j.1471-4159.2003.01879.x","article-title":"Hyperphosphorylation and aggregation of tau in mice expressing normal human Tau isoforms","volume":"86","author":"Andorfer","year":"2003","journal-title":"J Neurochem."},{"key":"B12","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1365-2796.2011.02389.x","article-title":"Enhanced production of the endogenous LXR ligand 24S-hydroxycholesterol is not sufficient to drive LXR-dependent gene expression in vivo","volume":"270","author":"Shafaati","year":"2011","journal-title":"J Int Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.neulet.2013.09.003","article-title":"Oxysterols and Parkinson's disease","volume":"555","author":"Bj\u00f6rkhem","year":"2013","journal-title":"Neurosci Lett."},{"key":"B14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.neuropharm.2008.06.068","article-title":"Antidepressants reverse the attenuation of the neurotrophic MEK\/MAPK cascade in frontal cortex by elevated platform stress; reversal of effects on LTP is associated with GluA1 phosphorylation","volume":"56","author":"Qi","year":"2009","journal-title":"Neuropharmacology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1515\/CCLM.2004.034","article-title":"Diagnostic use of cerebral and extracerebral oxysterols","volume":"42","author":"Leoni","year":"2004","journal-title":"Clin Chem Lab Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"9799","DOI":"10.1073\/pnas.93.18.9799","article-title":"Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation","volume":"93","author":"L\u00fctjohann","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"B17","doi-asserted-by":"publisher","first-page":"5966","DOI":"10.1093\/hmg\/ddv268","article-title":"Cholesterol 24-hydroxylase is implicated in memory impairment associated with Alzheimer-like Tau pathology","volume":"24","author":"Burlot","year":"2015","journal-title":"Hum Mol Genet."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2018.00756\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T00:33:36Z","timestamp":1536280416000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fneur.2018.00756\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,7]]},"references-count":17,"alternative-id":["10.3389\/fneur.2018.00756"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2018.00756","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,7]]},"article-number":"756"}}